nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Etoposide—brain cancer	0.0491	1	CbGbCtD
Zoledronate—GGPS1—hindbrain—brain cancer	0.0275	0.0915	CbGeAlD
Zoledronate—GGPS1—brainstem—brain cancer	0.0157	0.0524	CbGeAlD
Zoledronate—GGPS1—telencephalon—brain cancer	0.014	0.0465	CbGeAlD
Zoledronate—GGPS1—gonad—brain cancer	0.0117	0.0388	CbGeAlD
Zoledronate—GGPS1—pituitary gland—brain cancer	0.0114	0.0379	CbGeAlD
Zoledronate—GGPS1—medulla oblongata—brain cancer	0.011	0.0366	CbGeAlD
Zoledronate—GGPS1—midbrain—brain cancer	0.01	0.0334	CbGeAlD
Zoledronate—GGPS1—spinal cord—brain cancer	0.00979	0.0326	CbGeAlD
Zoledronate—GGPS1—endocrine gland—brain cancer	0.00881	0.0293	CbGeAlD
Zoledronate—GGPS1—head—brain cancer	0.0087	0.029	CbGeAlD
Zoledronate—CA14—telencephalon—brain cancer	0.00835	0.0278	CbGeAlD
Zoledronate—GGPS1—central nervous system—brain cancer	0.00794	0.0264	CbGeAlD
Zoledronate—GGPS1—cerebellum—brain cancer	0.00776	0.0258	CbGeAlD
Zoledronate—CA2—hindbrain—brain cancer	0.00657	0.0219	CbGeAlD
Zoledronate—CA14—medulla oblongata—brain cancer	0.00656	0.0219	CbGeAlD
Zoledronate—CA12—telencephalon—brain cancer	0.00651	0.0217	CbGeAlD
Zoledronate—FDPS—telencephalon—brain cancer	0.00644	0.0214	CbGeAlD
Zoledronate—GGPS1—brain—brain cancer	0.0063	0.021	CbGeAlD
Zoledronate—CA14—midbrain—brain cancer	0.00599	0.02	CbGeAlD
Zoledronate—CA14—spinal cord—brain cancer	0.00585	0.0195	CbGeAlD
Zoledronate—FDPS—gonad—brain cancer	0.00537	0.0179	CbGeAlD
Zoledronate—FDPS—pituitary gland—brain cancer	0.00524	0.0175	CbGeAlD
Zoledronate—FDPS—medulla oblongata—brain cancer	0.00506	0.0169	CbGeAlD
Zoledronate—CA14—cerebellum—brain cancer	0.00464	0.0154	CbGeAlD
Zoledronate—FDPS—midbrain—brain cancer	0.00462	0.0154	CbGeAlD
Zoledronate—FDPS—spinal cord—brain cancer	0.00451	0.015	CbGeAlD
Zoledronate—CA12—endocrine gland—brain cancer	0.00411	0.0137	CbGeAlD
Zoledronate—FDPS—endocrine gland—brain cancer	0.00406	0.0135	CbGeAlD
Zoledronate—CA12—head—brain cancer	0.00405	0.0135	CbGeAlD
Zoledronate—FDPS—head—brain cancer	0.00401	0.0134	CbGeAlD
Zoledronate—CA14—brain—brain cancer	0.00377	0.0125	CbGeAlD
Zoledronate—CA2—brainstem—brain cancer	0.00377	0.0125	CbGeAlD
Zoledronate—ABCC1—telencephalon—brain cancer	0.00374	0.0125	CbGeAlD
Zoledronate—CA12—central nervous system—brain cancer	0.0037	0.0123	CbGeAlD
Zoledronate—FDPS—central nervous system—brain cancer	0.00366	0.0122	CbGeAlD
Zoledronate—FDPS—cerebellum—brain cancer	0.00358	0.0119	CbGeAlD
Zoledronate—CA2—telencephalon—brain cancer	0.00334	0.0111	CbGeAlD
Zoledronate—ABCC1—pituitary gland—brain cancer	0.00304	0.0101	CbGeAlD
Zoledronate—CA12—brain—brain cancer	0.00294	0.00979	CbGeAlD
Zoledronate—FDPS—brain—brain cancer	0.00291	0.00968	CbGeAlD
Zoledronate—CA2—pituitary gland—brain cancer	0.00272	0.00907	CbGeAlD
Zoledronate—CA2—medulla oblongata—brain cancer	0.00263	0.00875	CbGeAlD
Zoledronate—CA2—midbrain—brain cancer	0.0024	0.008	CbGeAlD
Zoledronate—CA2—spinal cord—brain cancer	0.00234	0.0078	CbGeAlD
Zoledronate—CA2—endocrine gland—brain cancer	0.00211	0.00702	CbGeAlD
Zoledronate—CA2—head—brain cancer	0.00208	0.00693	CbGeAlD
Zoledronate—ABCC1—cerebellum—brain cancer	0.00208	0.00692	CbGeAlD
Zoledronate—CA2—central nervous system—brain cancer	0.0019	0.00633	CbGeAlD
Zoledronate—CA2—cerebellum—brain cancer	0.00186	0.00619	CbGeAlD
Zoledronate—ABCC1—brain—brain cancer	0.00169	0.00562	CbGeAlD
Zoledronate—Nausea—Lomustine—brain cancer	0.00152	0.00234	CcSEcCtD
Zoledronate—Hypotension—Procarbazine—brain cancer	0.00152	0.00234	CcSEcCtD
Zoledronate—CA2—brain—brain cancer	0.00151	0.00502	CbGeAlD
Zoledronate—Stomatitis—Temozolomide—brain cancer	0.00151	0.00231	CcSEcCtD
Zoledronate—Urinary tract infection—Temozolomide—brain cancer	0.0015	0.00231	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00148	0.00228	CcSEcCtD
Zoledronate—Insomnia—Procarbazine—brain cancer	0.00147	0.00226	CcSEcCtD
Zoledronate—Paraesthesia—Procarbazine—brain cancer	0.00146	0.00225	CcSEcCtD
Zoledronate—Somnolence—Procarbazine—brain cancer	0.00145	0.00223	CcSEcCtD
Zoledronate—Cramp muscle—Etoposide—brain cancer	0.00144	0.00222	CcSEcCtD
Zoledronate—Ill-defined disorder—Hydroxyurea—brain cancer	0.00143	0.0022	CcSEcCtD
Zoledronate—Anaemia—Hydroxyurea—brain cancer	0.00143	0.00219	CcSEcCtD
Zoledronate—Hypoaesthesia—Carmustine—brain cancer	0.00143	0.00219	CcSEcCtD
Zoledronate—Decreased appetite—Procarbazine—brain cancer	0.00142	0.00218	CcSEcCtD
Zoledronate—Oedema peripheral—Carmustine—brain cancer	0.00141	0.00217	CcSEcCtD
Zoledronate—Connective tissue disorder—Carmustine—brain cancer	0.00141	0.00217	CcSEcCtD
Zoledronate—Fatigue—Procarbazine—brain cancer	0.0014	0.00216	CcSEcCtD
Zoledronate—Malaise—Hydroxyurea—brain cancer	0.00139	0.00214	CcSEcCtD
Zoledronate—Constipation—Procarbazine—brain cancer	0.00139	0.00214	CcSEcCtD
Zoledronate—Pain—Procarbazine—brain cancer	0.00139	0.00214	CcSEcCtD
Zoledronate—Dysphagia—Etoposide—brain cancer	0.00139	0.00213	CcSEcCtD
Zoledronate—Leukopenia—Hydroxyurea—brain cancer	0.00138	0.00212	CcSEcCtD
Zoledronate—Hypoaesthesia—Temozolomide—brain cancer	0.00138	0.00212	CcSEcCtD
Zoledronate—Urinary tract disorder—Temozolomide—brain cancer	0.00137	0.0021	CcSEcCtD
Zoledronate—Oedema peripheral—Temozolomide—brain cancer	0.00137	0.0021	CcSEcCtD
Zoledronate—Bronchospasm—Etoposide—brain cancer	0.00136	0.00209	CcSEcCtD
Zoledronate—Connective tissue disorder—Temozolomide—brain cancer	0.00136	0.00209	CcSEcCtD
Zoledronate—Urethral disorder—Temozolomide—brain cancer	0.00136	0.00209	CcSEcCtD
Zoledronate—Sweating increased—Etoposide—brain cancer	0.00135	0.00207	CcSEcCtD
Zoledronate—Feeling abnormal—Procarbazine—brain cancer	0.00134	0.00206	CcSEcCtD
Zoledronate—Eye disorder—Carmustine—brain cancer	0.00134	0.00206	CcSEcCtD
Zoledronate—Convulsion—Hydroxyurea—brain cancer	0.00134	0.00206	CcSEcCtD
Zoledronate—Gastrointestinal pain—Procarbazine—brain cancer	0.00133	0.00205	CcSEcCtD
Zoledronate—Flushing—Carmustine—brain cancer	0.00133	0.00205	CcSEcCtD
Zoledronate—Pancytopenia—Etoposide—brain cancer	0.00132	0.00202	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00131	0.00201	CcSEcCtD
Zoledronate—Discomfort—Hydroxyurea—brain cancer	0.0013	0.002	CcSEcCtD
Zoledronate—Neutropenia—Etoposide—brain cancer	0.0013	0.00199	CcSEcCtD
Zoledronate—Eye disorder—Temozolomide—brain cancer	0.0013	0.00199	CcSEcCtD
Zoledronate—Urticaria—Procarbazine—brain cancer	0.00129	0.00199	CcSEcCtD
Zoledronate—Abdominal pain—Procarbazine—brain cancer	0.00129	0.00198	CcSEcCtD
Zoledronate—Body temperature increased—Procarbazine—brain cancer	0.00129	0.00198	CcSEcCtD
Zoledronate—Cardiac disorder—Temozolomide—brain cancer	0.00129	0.00198	CcSEcCtD
Zoledronate—Flushing—Temozolomide—brain cancer	0.00129	0.00198	CcSEcCtD
Zoledronate—Arrhythmia—Carmustine—brain cancer	0.00128	0.00197	CcSEcCtD
Zoledronate—Alopecia—Carmustine—brain cancer	0.00127	0.00195	CcSEcCtD
Zoledronate—Oedema—Hydroxyurea—brain cancer	0.00126	0.00194	CcSEcCtD
Zoledronate—Angiopathy—Temozolomide—brain cancer	0.00126	0.00193	CcSEcCtD
Zoledronate—Mental disorder—Carmustine—brain cancer	0.00126	0.00193	CcSEcCtD
Zoledronate—Infection—Hydroxyurea—brain cancer	0.00125	0.00192	CcSEcCtD
Zoledronate—Immune system disorder—Temozolomide—brain cancer	0.00125	0.00192	CcSEcCtD
Zoledronate—Mediastinal disorder—Temozolomide—brain cancer	0.00125	0.00192	CcSEcCtD
Zoledronate—Erythema—Carmustine—brain cancer	0.00125	0.00192	CcSEcCtD
Zoledronate—Malnutrition—Carmustine—brain cancer	0.00125	0.00192	CcSEcCtD
Zoledronate—Chills—Temozolomide—brain cancer	0.00124	0.00191	CcSEcCtD
Zoledronate—Nervous system disorder—Hydroxyurea—brain cancer	0.00124	0.0019	CcSEcCtD
Zoledronate—Infestation NOS—Etoposide—brain cancer	0.00124	0.0019	CcSEcCtD
Zoledronate—Infestation—Etoposide—brain cancer	0.00124	0.0019	CcSEcCtD
Zoledronate—Thrombocytopenia—Hydroxyurea—brain cancer	0.00123	0.0019	CcSEcCtD
Zoledronate—Alopecia—Temozolomide—brain cancer	0.00122	0.00188	CcSEcCtD
Zoledronate—Skin disorder—Hydroxyurea—brain cancer	0.00122	0.00188	CcSEcCtD
Zoledronate—Renal failure—Etoposide—brain cancer	0.00121	0.00187	CcSEcCtD
Zoledronate—Mental disorder—Temozolomide—brain cancer	0.00121	0.00187	CcSEcCtD
Zoledronate—Back pain—Carmustine—brain cancer	0.00121	0.00186	CcSEcCtD
Zoledronate—Erythema—Temozolomide—brain cancer	0.00121	0.00185	CcSEcCtD
Zoledronate—Malnutrition—Temozolomide—brain cancer	0.00121	0.00185	CcSEcCtD
Zoledronate—Stomatitis—Etoposide—brain cancer	0.0012	0.00185	CcSEcCtD
Zoledronate—Anorexia—Hydroxyurea—brain cancer	0.0012	0.00185	CcSEcCtD
Zoledronate—Hypersensitivity—Procarbazine—brain cancer	0.0012	0.00184	CcSEcCtD
Zoledronate—Dysgeusia—Temozolomide—brain cancer	0.00118	0.00182	CcSEcCtD
Zoledronate—Vision blurred—Carmustine—brain cancer	0.00118	0.00181	CcSEcCtD
Zoledronate—Tremor—Carmustine—brain cancer	0.00117	0.0018	CcSEcCtD
Zoledronate—Asthenia—Procarbazine—brain cancer	0.00117	0.0018	CcSEcCtD
Zoledronate—Back pain—Temozolomide—brain cancer	0.00117	0.00179	CcSEcCtD
Zoledronate—Anaemia—Carmustine—brain cancer	0.00115	0.00177	CcSEcCtD
Zoledronate—Agranulocytosis—Etoposide—brain cancer	0.00115	0.00177	CcSEcCtD
Zoledronate—Pruritus—Procarbazine—brain cancer	0.00115	0.00177	CcSEcCtD
Zoledronate—Agitation—Carmustine—brain cancer	0.00115	0.00176	CcSEcCtD
Zoledronate—Vision blurred—Temozolomide—brain cancer	0.00114	0.00175	CcSEcCtD
Zoledronate—Tremor—Temozolomide—brain cancer	0.00113	0.00174	CcSEcCtD
Zoledronate—Dyspnoea—Hydroxyurea—brain cancer	0.00112	0.00173	CcSEcCtD
Zoledronate—Somnolence—Hydroxyurea—brain cancer	0.00112	0.00172	CcSEcCtD
Zoledronate—Ill-defined disorder—Temozolomide—brain cancer	0.00112	0.00172	CcSEcCtD
Zoledronate—Leukopenia—Carmustine—brain cancer	0.00112	0.00172	CcSEcCtD
Zoledronate—Anaemia—Temozolomide—brain cancer	0.00112	0.00171	CcSEcCtD
Zoledronate—Diarrhoea—Procarbazine—brain cancer	0.00111	0.00171	CcSEcCtD
Zoledronate—Dyspepsia—Hydroxyurea—brain cancer	0.00111	0.00171	CcSEcCtD
Zoledronate—Agitation—Temozolomide—brain cancer	0.00111	0.0017	CcSEcCtD
Zoledronate—Hypoaesthesia—Etoposide—brain cancer	0.0011	0.0017	CcSEcCtD
Zoledronate—Angioedema—Temozolomide—brain cancer	0.0011	0.00169	CcSEcCtD
Zoledronate—Decreased appetite—Hydroxyurea—brain cancer	0.0011	0.00168	CcSEcCtD
Zoledronate—Urinary tract disorder—Etoposide—brain cancer	0.0011	0.00168	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00109	0.00167	CcSEcCtD
Zoledronate—Malaise—Temozolomide—brain cancer	0.00109	0.00167	CcSEcCtD
Zoledronate—Urethral disorder—Etoposide—brain cancer	0.00109	0.00167	CcSEcCtD
Zoledronate—Fatigue—Hydroxyurea—brain cancer	0.00109	0.00167	CcSEcCtD
Zoledronate—Vertigo—Temozolomide—brain cancer	0.00108	0.00167	CcSEcCtD
Zoledronate—Convulsion—Carmustine—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Leukopenia—Temozolomide—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Hypertension—Carmustine—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Constipation—Hydroxyurea—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Pain—Hydroxyurea—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Dizziness—Procarbazine—brain cancer	0.00108	0.00166	CcSEcCtD
Zoledronate—Palpitations—Temozolomide—brain cancer	0.00107	0.00164	CcSEcCtD
Zoledronate—Chest pain—Carmustine—brain cancer	0.00106	0.00163	CcSEcCtD
Zoledronate—Myalgia—Carmustine—brain cancer	0.00106	0.00163	CcSEcCtD
Zoledronate—Anxiety—Carmustine—brain cancer	0.00106	0.00163	CcSEcCtD
Zoledronate—Cough—Temozolomide—brain cancer	0.00105	0.00162	CcSEcCtD
Zoledronate—Convulsion—Temozolomide—brain cancer	0.00105	0.00161	CcSEcCtD
Zoledronate—Hypertension—Temozolomide—brain cancer	0.00104	0.0016	CcSEcCtD
Zoledronate—Feeling abnormal—Hydroxyurea—brain cancer	0.00104	0.0016	CcSEcCtD
Zoledronate—Eye disorder—Etoposide—brain cancer	0.00104	0.00159	CcSEcCtD
Zoledronate—Vomiting—Procarbazine—brain cancer	0.00104	0.00159	CcSEcCtD
Zoledronate—Cardiac disorder—Etoposide—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Flushing—Etoposide—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Confusional state—Carmustine—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Arthralgia—Temozolomide—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Myalgia—Temozolomide—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Rash—Procarbazine—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Dermatitis—Procarbazine—brain cancer	0.00103	0.00158	CcSEcCtD
Zoledronate—Anxiety—Temozolomide—brain cancer	0.00102	0.00157	CcSEcCtD
Zoledronate—Headache—Procarbazine—brain cancer	0.00102	0.00157	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00102	0.00157	CcSEcCtD
Zoledronate—Oedema—Carmustine—brain cancer	0.00102	0.00157	CcSEcCtD
Zoledronate—Discomfort—Temozolomide—brain cancer	0.00102	0.00156	CcSEcCtD
Zoledronate—Infection—Carmustine—brain cancer	0.00101	0.00156	CcSEcCtD
Zoledronate—Angiopathy—Etoposide—brain cancer	0.00101	0.00155	CcSEcCtD
Zoledronate—Dry mouth—Temozolomide—brain cancer	0.001	0.00154	CcSEcCtD
Zoledronate—Immune system disorder—Etoposide—brain cancer	0.001	0.00154	CcSEcCtD
Zoledronate—Mediastinal disorder—Etoposide—brain cancer	0.001	0.00154	CcSEcCtD
Zoledronate—Thrombocytopenia—Carmustine—brain cancer	0.000998	0.00153	CcSEcCtD
Zoledronate—Body temperature increased—Hydroxyurea—brain cancer	0.000997	0.00153	CcSEcCtD
Zoledronate—Chills—Etoposide—brain cancer	0.000995	0.00153	CcSEcCtD
Zoledronate—Tachycardia—Carmustine—brain cancer	0.000995	0.00153	CcSEcCtD
Zoledronate—Confusional state—Temozolomide—brain cancer	0.000993	0.00153	CcSEcCtD
Zoledronate—Oedema—Temozolomide—brain cancer	0.000985	0.00151	CcSEcCtD
Zoledronate—Anaphylactic shock—Temozolomide—brain cancer	0.000985	0.00151	CcSEcCtD
Zoledronate—Alopecia—Etoposide—brain cancer	0.00098	0.00151	CcSEcCtD
Zoledronate—Infection—Temozolomide—brain cancer	0.000978	0.0015	CcSEcCtD
Zoledronate—Anorexia—Carmustine—brain cancer	0.000971	0.00149	CcSEcCtD
Zoledronate—Nausea—Procarbazine—brain cancer	0.000968	0.00149	CcSEcCtD
Zoledronate—Nervous system disorder—Temozolomide—brain cancer	0.000966	0.00148	CcSEcCtD
Zoledronate—Thrombocytopenia—Temozolomide—brain cancer	0.000964	0.00148	CcSEcCtD
Zoledronate—Skin disorder—Temozolomide—brain cancer	0.000957	0.00147	CcSEcCtD
Zoledronate—Hypotension—Carmustine—brain cancer	0.000952	0.00146	CcSEcCtD
Zoledronate—Hyperhidrosis—Temozolomide—brain cancer	0.000952	0.00146	CcSEcCtD
Zoledronate—Dysgeusia—Etoposide—brain cancer	0.000946	0.00145	CcSEcCtD
Zoledronate—Anorexia—Temozolomide—brain cancer	0.000939	0.00144	CcSEcCtD
Zoledronate—Back pain—Etoposide—brain cancer	0.000934	0.00144	CcSEcCtD
Zoledronate—Hypersensitivity—Hydroxyurea—brain cancer	0.000929	0.00143	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Carmustine—brain cancer	0.000928	0.00143	CcSEcCtD
Zoledronate—Muscle spasms—Etoposide—brain cancer	0.000928	0.00143	CcSEcCtD
Zoledronate—Insomnia—Carmustine—brain cancer	0.000922	0.00142	CcSEcCtD
Zoledronate—Paraesthesia—Carmustine—brain cancer	0.000915	0.00141	CcSEcCtD
Zoledronate—Dyspnoea—Carmustine—brain cancer	0.000909	0.0014	CcSEcCtD
Zoledronate—Somnolence—Carmustine—brain cancer	0.000906	0.00139	CcSEcCtD
Zoledronate—Asthenia—Hydroxyurea—brain cancer	0.000904	0.00139	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000897	0.00138	CcSEcCtD
Zoledronate—Ill-defined disorder—Etoposide—brain cancer	0.000896	0.00138	CcSEcCtD
Zoledronate—Anaemia—Etoposide—brain cancer	0.000892	0.00137	CcSEcCtD
Zoledronate—Insomnia—Temozolomide—brain cancer	0.000891	0.00137	CcSEcCtD
Zoledronate—Decreased appetite—Carmustine—brain cancer	0.000886	0.00136	CcSEcCtD
Zoledronate—Paraesthesia—Temozolomide—brain cancer	0.000884	0.00136	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Carmustine—brain cancer	0.00088	0.00135	CcSEcCtD
Zoledronate—Dyspnoea—Temozolomide—brain cancer	0.000878	0.00135	CcSEcCtD
Zoledronate—Somnolence—Temozolomide—brain cancer	0.000876	0.00135	CcSEcCtD
Zoledronate—Constipation—Carmustine—brain cancer	0.000871	0.00134	CcSEcCtD
Zoledronate—Pain—Carmustine—brain cancer	0.000871	0.00134	CcSEcCtD
Zoledronate—Malaise—Etoposide—brain cancer	0.000871	0.00134	CcSEcCtD
Zoledronate—Vertigo—Etoposide—brain cancer	0.000868	0.00133	CcSEcCtD
Zoledronate—Dyspepsia—Temozolomide—brain cancer	0.000867	0.00133	CcSEcCtD
Zoledronate—Leukopenia—Etoposide—brain cancer	0.000864	0.00133	CcSEcCtD
Zoledronate—Diarrhoea—Hydroxyurea—brain cancer	0.000863	0.00133	CcSEcCtD
Zoledronate—Decreased appetite—Temozolomide—brain cancer	0.000856	0.00132	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Temozolomide—brain cancer	0.00085	0.00131	CcSEcCtD
Zoledronate—Fatigue—Temozolomide—brain cancer	0.000849	0.0013	CcSEcCtD
Zoledronate—Loss of consciousness—Etoposide—brain cancer	0.000849	0.0013	CcSEcCtD
Zoledronate—Cough—Etoposide—brain cancer	0.000843	0.00129	CcSEcCtD
Zoledronate—Pain—Temozolomide—brain cancer	0.000842	0.00129	CcSEcCtD
Zoledronate—Constipation—Temozolomide—brain cancer	0.000842	0.00129	CcSEcCtD
Zoledronate—Feeling abnormal—Carmustine—brain cancer	0.00084	0.00129	CcSEcCtD
Zoledronate—Convulsion—Etoposide—brain cancer	0.000837	0.00129	CcSEcCtD
Zoledronate—Hypertension—Etoposide—brain cancer	0.000834	0.00128	CcSEcCtD
Zoledronate—Dizziness—Hydroxyurea—brain cancer	0.000834	0.00128	CcSEcCtD
Zoledronate—Gastrointestinal pain—Carmustine—brain cancer	0.000833	0.00128	CcSEcCtD
Zoledronate—Chest pain—Etoposide—brain cancer	0.000822	0.00126	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000816	0.00125	CcSEcCtD
Zoledronate—Discomfort—Etoposide—brain cancer	0.000812	0.00125	CcSEcCtD
Zoledronate—Feeling abnormal—Temozolomide—brain cancer	0.000812	0.00125	CcSEcCtD
Zoledronate—Abdominal pain—Carmustine—brain cancer	0.000806	0.00124	CcSEcCtD
Zoledronate—Body temperature increased—Carmustine—brain cancer	0.000806	0.00124	CcSEcCtD
Zoledronate—Gastrointestinal pain—Temozolomide—brain cancer	0.000805	0.00124	CcSEcCtD
Zoledronate—Vomiting—Hydroxyurea—brain cancer	0.000802	0.00123	CcSEcCtD
Zoledronate—Rash—Hydroxyurea—brain cancer	0.000795	0.00122	CcSEcCtD
Zoledronate—Confusional state—Etoposide—brain cancer	0.000795	0.00122	CcSEcCtD
Zoledronate—Dermatitis—Hydroxyurea—brain cancer	0.000794	0.00122	CcSEcCtD
Zoledronate—Headache—Hydroxyurea—brain cancer	0.00079	0.00121	CcSEcCtD
Zoledronate—Anaphylactic shock—Etoposide—brain cancer	0.000788	0.00121	CcSEcCtD
Zoledronate—Infection—Etoposide—brain cancer	0.000783	0.0012	CcSEcCtD
Zoledronate—Urticaria—Temozolomide—brain cancer	0.000782	0.0012	CcSEcCtD
Zoledronate—Abdominal pain—Temozolomide—brain cancer	0.000779	0.0012	CcSEcCtD
Zoledronate—Body temperature increased—Temozolomide—brain cancer	0.000779	0.0012	CcSEcCtD
Zoledronate—Thrombocytopenia—Etoposide—brain cancer	0.000772	0.00119	CcSEcCtD
Zoledronate—Tachycardia—Etoposide—brain cancer	0.000769	0.00118	CcSEcCtD
Zoledronate—Skin disorder—Etoposide—brain cancer	0.000765	0.00118	CcSEcCtD
Zoledronate—Hyperhidrosis—Etoposide—brain cancer	0.000762	0.00117	CcSEcCtD
Zoledronate—Anorexia—Etoposide—brain cancer	0.000751	0.00115	CcSEcCtD
Zoledronate—Hypersensitivity—Carmustine—brain cancer	0.000751	0.00115	CcSEcCtD
Zoledronate—Nausea—Hydroxyurea—brain cancer	0.000749	0.00115	CcSEcCtD
Zoledronate—Hypotension—Etoposide—brain cancer	0.000736	0.00113	CcSEcCtD
Zoledronate—Asthenia—Carmustine—brain cancer	0.000731	0.00112	CcSEcCtD
Zoledronate—Hypersensitivity—Temozolomide—brain cancer	0.000726	0.00112	CcSEcCtD
Zoledronate—Paraesthesia—Etoposide—brain cancer	0.000708	0.00109	CcSEcCtD
Zoledronate—Asthenia—Temozolomide—brain cancer	0.000707	0.00109	CcSEcCtD
Zoledronate—Dyspnoea—Etoposide—brain cancer	0.000703	0.00108	CcSEcCtD
Zoledronate—Somnolence—Etoposide—brain cancer	0.000701	0.00108	CcSEcCtD
Zoledronate—Diarrhoea—Carmustine—brain cancer	0.000697	0.00107	CcSEcCtD
Zoledronate—Pruritus—Temozolomide—brain cancer	0.000697	0.00107	CcSEcCtD
Zoledronate—Decreased appetite—Etoposide—brain cancer	0.000685	0.00105	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Etoposide—brain cancer	0.00068	0.00105	CcSEcCtD
Zoledronate—Fatigue—Etoposide—brain cancer	0.000679	0.00104	CcSEcCtD
Zoledronate—Dizziness—Carmustine—brain cancer	0.000674	0.00104	CcSEcCtD
Zoledronate—Pain—Etoposide—brain cancer	0.000674	0.00104	CcSEcCtD
Zoledronate—Constipation—Etoposide—brain cancer	0.000674	0.00104	CcSEcCtD
Zoledronate—Diarrhoea—Temozolomide—brain cancer	0.000674	0.00104	CcSEcCtD
Zoledronate—Dizziness—Temozolomide—brain cancer	0.000651	0.001	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—brain cancer	0.000649	0.000998	CcSEcCtD
Zoledronate—Vomiting—Carmustine—brain cancer	0.000648	0.000996	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—brain cancer	0.000644	0.00099	CcSEcCtD
Zoledronate—Rash—Carmustine—brain cancer	0.000643	0.000987	CcSEcCtD
Zoledronate—Dermatitis—Carmustine—brain cancer	0.000642	0.000987	CcSEcCtD
Zoledronate—Headache—Carmustine—brain cancer	0.000638	0.000981	CcSEcCtD
Zoledronate—Vomiting—Temozolomide—brain cancer	0.000626	0.000962	CcSEcCtD
Zoledronate—Urticaria—Etoposide—brain cancer	0.000626	0.000962	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—brain cancer	0.000623	0.000957	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—brain cancer	0.000623	0.000957	CcSEcCtD
Zoledronate—Rash—Temozolomide—brain cancer	0.000621	0.000954	CcSEcCtD
Zoledronate—Dermatitis—Temozolomide—brain cancer	0.00062	0.000953	CcSEcCtD
Zoledronate—Headache—Temozolomide—brain cancer	0.000617	0.000948	CcSEcCtD
Zoledronate—Nausea—Carmustine—brain cancer	0.000605	0.00093	CcSEcCtD
Zoledronate—Nausea—Temozolomide—brain cancer	0.000585	0.000899	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—brain cancer	0.000581	0.000892	CcSEcCtD
Zoledronate—Asthenia—Etoposide—brain cancer	0.000565	0.000869	CcSEcCtD
Zoledronate—Pruritus—Etoposide—brain cancer	0.000558	0.000857	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—brain cancer	0.000539	0.000829	CcSEcCtD
Zoledronate—Dizziness—Etoposide—brain cancer	0.000521	0.000801	CcSEcCtD
Zoledronate—Vomiting—Etoposide—brain cancer	0.000501	0.00077	CcSEcCtD
Zoledronate—Rash—Etoposide—brain cancer	0.000497	0.000764	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—brain cancer	0.000496	0.000763	CcSEcCtD
Zoledronate—Headache—Etoposide—brain cancer	0.000494	0.000759	CcSEcCtD
Zoledronate—Nausea—Etoposide—brain cancer	0.000468	0.000719	CcSEcCtD
